Table 9.

Analysis of patients hospitalized with coronavirus disease 2019 depending on the outcome of the disease

	Deceased	Recovered	P value
Total number, n/%	20/2.9	664/97.1
Male/female ratio	17/3	367/297	0.0081
Age, yr ± SD	64.3±11.9	50.45	0.0004
With normal enzymes, n/%	3/15.0	78/11.7	0.6554
With elevated enzymes, n/%	17/85.0	586/88.3
Moderate COVID, n/%	2/10.0	498/75.0	< 0.0001
Severe COVID, n/%	5/25.0	143/21.5
Critical COVID, n/%	13/65.0	23/3.5
Respiratory failure, n/%	17/85.0	53/8.0	< 0.0001
Respiratory rate, n/min ± SD	22.3 ± 5.6	18.2 ± 2.9	0.0099
SpO2, % ± SD	88.7 ± 6.3	94.6 ± 3.2	0.0010
O2 demand, n/%	11/55.0	198/29.8	0.0158
Bacterial pneumonia complication, n/%	5/25.0	364/54.8	0.0084
Sepsis, n/%	13/65.0	5/0.8	< 0.0001
Acute liver failure, n/%	4/20.0	1/0.15	< 0.0001
Acute kidney failure, n/%	10/50.0	6/0.9	< 0.0001
Electrolytes imbalance, n/%	11/55.0	64/9.6	< 0.0001
Antibiotic resistance, n/%	7/35.0	12/1.8	< 0.0001
Urinary tract infections, n/%	5/25.0	40/6.0	0.0007
Primary hypertension, n/%	10/50.0	204/30.7	0.0669
Heart disease, n/%	10/50.0	28/4.2	< 0.0001

COVID: Coronavirus disease.